Transforming growth factor-β and RAS regulate the VEGF/VEGF-receptor system during tumor angiogenesis

International Journal of Cancer

Volumn 97, Issue 2, 2002, Pages 142-148

  Breier, Georg ^a   Blum, Sabine ^a   Peli, Janos ^b   Groot, Marcel ^a   Wild, Carola ^a   Risau, Werner ^a   Reichmann, Ernst ^b  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

Flk 1; Ras; TGF ; Tumor angiogenesis; VEGF

Indexed keywords

RAS PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER MODEL; CELL MIGRATION; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; ANOXIA; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; FIBROBLASTS; GLIOMA; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; LYMPHOKINES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENE PROTEIN P21(RAS); RATS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; UMBILICAL VEINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037049982     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1599     Document Type: Article

References (53)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels
3. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
4. Role of vascular endothelial growth factor in the regulation of angiogenesis
5. Angiogenesis in malignant gliomas
6. Pathology, genetics and cell biology of hemangioblastomas
7. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
8. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis
9. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms
10. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells
11. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo
12. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis
13. The tumor-promoting effect of wounding: A possible role for TGF-beta-induced stromal alterations
14. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
15. Tenascin: cDNA cloning and induction by TGF-beta
16. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
17. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor
18. Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase
19. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells
20. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
21. High-efficiency transformation of mammalian cells by plasmid DNA
22. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium
23. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage
24. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development
25. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion
26. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
27. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only
28. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells
29. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing
30. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells
31. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
32. Vascular endothelial growth factor induces endothelial fenestrations in vitro
33. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression
34. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
35. Tumor angiogenesis in breast cancer - Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
36. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
37. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
38. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
39. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
40. Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane
41. Transforming growth factor beta-1 positively modulates the bioactivity of fibroblast growth factor on corneal endothelial cells
42. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: A proposed model for indirect mitogenesis involving autocrine activity
43. TGF-β stimulates primary human skin fibroblast DNA synthesis via an autocrine production of PDGF-related peptides
44. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta
45. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice
46. TGF-β2 knockout mice have multiple developmental defects that are nonoverlapping with other TGF-β knockout phenotypes
47. The expression of the platelet-derived and transforming growth factor genes in human nonsmall lung cancer cell lines is related to tumor stroma formation in nude mice tumors
48. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells
49. Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells
50. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system
51. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
52. Tumor endothelium-specific transgene expression directed by vascular endothelial growth factor receptor-2 (Flk-1) promoter/enhancer sequences
53. Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice